GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (BOM:532305) » Definitions » Float Percentage Of Total Shares Outstanding

Ind-Swift Laboratories (BOM:532305) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 21, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Ind-Swift Laboratories Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ind-Swift Laboratories's float shares is 0.00 Mil. Ind-Swift Laboratories's total shares outstanding is 60.62 Mil. Ind-Swift Laboratories's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ind-Swift Laboratories's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ind-Swift Laboratories's Institutional Ownership is 0.26%.


Ind-Swift Laboratories Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Ind-Swift Laboratories's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/60.62
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ind-Swift Laboratories Business Description

Industry
Traded in Other Exchanges
Address
SCO 850, NAC, Shivalik Enclave, Manimajra, Chandigarh, PB, IND, 160101
Ind-Swift Laboratories Ltd is engaged in the business of manufacturing Active Pharmaceutical Ingredients (API), Intermediates, and formulations. The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. It operates in a single segment namely, Bulk Drugs and Pharmaceuticals. Geographically, the company caters to both Indian and international markets, of which, maximum revenue is derived from outside India.

Ind-Swift Laboratories Headlines

No Headlines